article thumbnail

Pay it Forward: Capital Drives Bio Innovation in San Diego & Beyond

Xconomy

After starting Organovo in 2007, I spent much of the next decade as CEO seeking financing to advance our bioprinting technology. The change has caused me to reflect a bit on the state of finance in biotech and in San Diego biotech particularly. About 40 percent of my financing at.

article thumbnail

Venture Group’s Krenn Sees Improving VC Deals for SD Tech Startups

Xconomy

Call him an optimist if you must, but San Diego Venture Group president Mike Krenn says venture financings for San Diego’s early stage tech startups are on a tear. “I I haven’t seen it this good since 2007,” he says. Venture data, however, only partly support Krenn’s exhuberance.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Venture Activity Comes to (Unicorn) Point in 2017, and Top 10 Deals

Xconomy

But in the United States, it was the year of the unicorn—at least according to the Venture Monitor report released today by Seattle-based PitchBook and the National Venture Capital Association. A record number of unicorn financings—venture-backed companies valued at $1 billion or more—helped drive U.S.

article thumbnail

Former Biotech VC Steven Burrill Draws 30-Month Prison Term for Fraud

Xconomy

He was accused of diverting more than $18 million from the $283 million Burrill Life Sciences Capital Fund III under the guise of management fees. Those amounts, siphoned away during the period between December 2007 and September 2013, were not owed to him, according to a Department of Justice account. Burrill was also charged.

article thumbnail

Tragara Pharmaceuticals Snags $5M

socalTECH

San Diego-based Tragara Pharmaceuticals , a developer of biopharmaceuticals aimed at cancer and inflammation treatments, has raised another $5M in a funding round, according to a regulatory filing by the firm last week. The firm last raised a large, $40M funding round in 2007.

San Diego 140
article thumbnail

VentiRx Gets $25M In Series A Extension

socalTECH

San Diego-based biopharmaceuticals firm VentiRx Pharmaceuticals said today that the firm has raised $25M in a Series A extension round. The firm said the new funding, including its initial $26.6M, Series A funding in March of 2007, brings its total raised to $51.6M. of MedImmune Ventures, joins its board as part of the funding.

San Diego 140
article thumbnail

Qualcomm To Invest $150M In Startups In India

socalTECH

San Diego-based Qualcomm is planning to invest $150M in startups in India, the company said this weekend in an event with India's Prime Minister, Narendra Modi. According to Qualcomm, the investment will be directed by Qualcomm Ventures. READ MORE>>.

Invest 100